Sidra Medicine Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism
Sidra Medicine has successfully conducted Qatar's first industry-sponsored pharmaceutical trial for pediatric congenital hyperinsulinism, marking a significant advancement in treating this rare condition.
Sidra Medicine Launches Clinical Trials Program for Rare Pediatric Diseases in the Arab Region
Sidra Medicine initiates a clinical trials program focusing on rare and complex diseases affecting children in the Arab region, addressing a significant data gap.
© Copyright 2025. All Rights Reserved by MedPath